?
Sulzberger Gabrielle
Director
Eli Lilly and Company
US, Indianapolis [HQ]
CIK
1262388
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
2,155
Price per Share :
$725.72
Equivalence :
$1,563,926.60
Transaction History
-
A2,155 Shares After TransactionValue : $1,907,196.55$9,735.11Transaction Date : 06/17/24
-
Footnotes
-
-
Footnotes:#1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
-
A2,190 Shares After TransactionValue : $2,022,552.60$10,158.94Transaction Date : 09/16/24
-
Footnotes
-
-
Footnotes:#1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
-
A2,085 Shares After TransactionValue : $1,323,078.45$10,153.12Transaction Date : 01/16/24
-
Footnotes
-
-
Footnotes:#1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
-
A2,532,931 Shares After TransactionValue : $1,973,153,249.00$991,667.00Transaction Date : 12/16/24
-
Footnotes
-
-
Footnotes:#1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
-
A2,098 Shares After TransactionValue : $1,585,374.68$9,823.58Transaction Date : 02/20/24
-
Footnotes
-
-
Footnotes:#1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.